Genetic risk modeling for dementia offers significant benefits, but studies based on real-world data, particularly for underrepresented populations, are limited. 3 key findings →
Participants: 610
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
54/100
✓ Peer-reviewed
alzhub usefulness score 54 out of 100.
·
Neurology
·
2004-06-01
Deterioration in Alzheimer disease appears to be driven by neuritic plaques and neurofibrillary tangles at different stages of the disease. 4 key findings →
Participants: 102
Evidence: low
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
54/100
✓ Peer-reviewed
alzhub usefulness score 54 out of 100.
·
Neurology
·
1996-03-01
Previous research has shown that the Mini-Mental State Examination (MMS) is biased as a measure of cognitive impairment in minority and low-education patients. 3 key findings →
Participants: 590
Evidence: low
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
Depressive symptoms are cross-sectionally associated with cognitive impairment but not subsequent cognitive decline. 5 key findings →
Participants: 1,265
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
A registry of the University of Washington Alzheimer's Disease Research Center Satellite. 1 key finding →
Design: cross-sectional
Participants: 371
Evidence: low
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
54/100
✓ Peer-reviewed
alzhub usefulness score 54 out of 100.
·
Age and ageing
·
2021-01-01
Given considerable variation in diagnostic and therapeutic practice, there is a need for national guidance on the use of neuroimaging, fluid biomarkers, cognitive testing, follow-up and diagnostic terminology in mild cognitive impairment (MCI). 1 key finding →
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
54/100
✓ Peer-reviewed
alzhub usefulness score 54 out of 100.
·
Stroke
·
2005-05-05
These cross-sectional data provide evidence that tHcy is a risk factor for white matter damage. 1 key finding →
Design: cross-sectional
Participants: 259
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
In 1999, 17.7% (95% confidence interval [CI], 17.2-18.1) of patients with dementia were using atypical or conventional antipsychotics. 3 key findings →
Participants: 254
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
54/100
✓ Peer-reviewed
alzhub usefulness score 54 out of 100.
·
Neuropsychology
·
2013-11-04
This study does not support a protective effect of bilingualism on age-related cognitive decline or the development of dementia. 4 key findings →
Participants: 1,067
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Free full text
These results add to the body of evidence on the adverse impact of ambient air pollution on cognitive aging and brain health and provide new insights into the genetic and behavioral factors that may impact individual susceptibility. 4 key findings →
Participants: 4,821
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
This study shows that a minority of Dutch physicians find it conceivable that they would grant a request for EAS from a patient with psychiatric disease, dementia or a patient who is tired of living. 2 key findings →
Design: cross-sectional
Participants: 1,456
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
54/100
✓ Peer-reviewed
alzhub usefulness score 54 out of 100.
·
BMC public health
·
2009-10-21
Apparent better health in Daxing might be explained by under-diagnosis, under-reporting or selective mortality. 3 key findings →
Design: cross-sectional
Participants: 1,002
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
The defining feature of Parkinson disease (PD) and Lewy body dementia (LBD) is the accumulation of alpha-synuclein (Asyn) fibrils in Lewy bodies and Lewy neurites. 1 key finding →
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
Immigrant status may have complex effects on dementia risk. 5 key findings →
Design: cross-sectional
Participants: 7,609
Evidence: low
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
54/100
✓ Peer-reviewed
alzhub usefulness score 54 out of 100.
·
Neuroradiology
·
2019-03-09
Current practice in dementia imaging is fairly homogeneous across Europe, in terms of image acquisition and image interpretation. 1 key finding →
Participants: 1,662
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
Over the past decade it has become evident that a substantial minority of patients with primary dementing diseases, particularly those presenting in the presenium, have dementia of frontal lobe type (DFT) due to non-Alzheimer's pathology. 1 key finding →
Design: longitudinal study
Participants: 52
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
The incidence of PUs was 0.38 per person-year in the NH. 3 key findings →
Design: cohort study
Participants: 1,938
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
54/100
✓ Peer-reviewed
alzhub usefulness score 54 out of 100.
·
JAMA Network Open
·
2025-03-06
Of 8976 decedents (mean [SD] age, 81.3 [8.6] years; 4927 women [55.1%] women) in the cohort, 2197 (22.5%) were included in the low wealth category, 4534 (50.5%) in the medium wealth category, and 2245 (27.1%) in the high wealth category. 5 key findings →
Design: cohort study
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Free full text
This diverse sample of Indigenous (1.65%), Black (11.43%), Hispanic (9.85%), and White (77.07%) older adults had a mean age of 61 (SD = 9.66) and was 52% female. 4 key findings →
Design: longitudinal study
Participants: 27,327
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Free full text
Bivariate analyses indicated that nonmetro dementia caregivers were less racially/ethnically diverse (82.7% White, non-Hispanic) and more were spouses/partners (20.2%) than their metro counterparts (66.6% White, non-Hispanic; 13.3% spouses/partners). 5 key findings →
Participants: 808
Evidence: low
Full summary, score breakdown and related studies →
Original source
The sample included 993 decedents with dementia (81.4% white; 11.0% black, 7.6% hispanic). 5 key findings →
Participants: 993
Evidence: low
Full summary, score breakdown and related studies →
Original source
As indicated by Cox regression modeling, dementia risk of low-educated individuals was not significantly different between ethnic groups but was related to having an APOE e4 allele (hazard ratio [HR] 1.89), depression (HR 1.67), stroke (HR 1.60), and smoking (HR 1.32). 3 key findings →
Participants: 819
Evidence: low
Full summary, score breakdown and related studies →
Original source
In total, 740 proteins were identified of which, 25 differentially-expressed proteins in AD came from comparisons within a single racial and ethnic background group. 5 key findings →
Participants: 113
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Participants indicated that they are concerned about cognitive decline, are willing to plan for their future care and cognitive testing, and articulated a desire for Tribally led long-term support services. 4 key findings →
Participants: 50
Evidence: low
Full summary, score breakdown and related studies →
Original source
Minoritized individuals had lower scores and/or greater likelihood of impairment on measures of lexical retrieval, processing speed, cognitive flexibility, and working memory but not global cognition, verbal recall, attention, and category fluency. 5 key findings →
Participants: 56
Evidence: low
Full summary, score breakdown and related studies →
Original source
How the 0–100 score works — and why some entries are capped
This is alzhub's own score. It is not an official metric, not an impact factor,
and no journal, publisher or ranking body endorses it. We built it so that a reader who is not a
scientist can tell a landmark trial from a conference abstract without having to already know the
difference. Every point comes from one of 20 components, all of them printed on the study itself,
so you can disagree with our arithmetic rather than having to trust the total.
- Journal tier up to 10 pts
- Journal's citation record up to 4 pts
- Study design up to 12 pts
- Strength of evidence up to 5 pts
- Peer-review validation up to 10 pts
- How recent up to 5 pts
- Sample size up to 4 pts
- Effect reported up to 3 pts
- Studied in people up to 3 pts
- Randomised / blinded up to 2 pts
- Times cited up to 7 pts
- Citations per year up to 5 pts
- Impact for its field and year up to 6 pts
- Cited by studies here up to 6 pts
- Still being cited up to 4 pts
- Senior author's track record up to 4 pts
- Institution's track record up to 3 pts
- Multi-centre collaboration up to 3 pts
- Indexed in PubMed up to 2 pts
- Free to read up to 2 pts
Journals are placed in ordered tiers, never given a numeric impact factor — we
could not verify current impact factors from a source we control, and an invented one would be
worse than none. Tier 1 is the top-tier general journals (NEJM, The Lancet, JAMA, Nature, Science,
Nature Medicine); tier 2 is the leading specialty journals; tier 3 is every other peer-reviewed
journal. A separate part scores how much the journal's own papers are cited, which tells the
tier-3 journals apart.
Two rules we don't bend. First, we never fill in a
missing value: if a record does not state a sample size or a design, that component scores
zero, and if we simply have no data for a part, such as a citation count, that part is left out and
the study is scored on the parts we could check. The study card says which. Second, anything that is not a peer-reviewed
article is capped at 16/100 and carries a warning chip — so a conference abstract or
a company press release can never outrank a peer-reviewed paper, no matter how good it looks.
We rank a rigorous null result — a good trial showing that something does not
work — above an early positive finding. Someone deciding whether to buy a supplement is served by
that, and the rigour is already counted by the design and journal components.
The score is computed from the published data alone and is
reproducible: the same file always yields the same numbers.
See the whole rubric drawn out →
— four charts covering all 27,780 studies: how the scores are spread and where the cap
bites, which of the 20 components the library is strong and weak on, which subjects rest on
stronger evidence, and what kinds of study each subject is actually built from.